Grantham, Mayo, Van Otterloo & Co (GMO)’s BCE BCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,800
Closed -$225K 581
2017
Q3
$225K Sell
4,800
-12,000
-71% -$562K ﹤0.01% 523
2017
Q2
$757K Sell
16,800
-36,500
-68% -$1.65M ﹤0.01% 389
2017
Q1
$2.36M Sell
53,300
-880,420
-94% -$38.8M 0.01% 312
2016
Q4
$40.4M Sell
933,720
-523,680
-36% -$23.1M 0.22% 105
2016
Q3
$67.2M Sell
1,457,400
-384,800
-21% -$18.2M 0.32% 80
2016
Q2
$86.8M Buy
1,842,200
+212,900
+13% +$9.87M 0.36% 67
2016
Q1
$74.5M Buy
1,629,300
+579,436
+55% +$24.2M 0.28% 78
2015
Q4
$40.4M Buy
1,049,864
+123,864
+13% +$5.22M 0.15% 119
2015
Q3
$37.7M Buy
+926,000
New +$38M 0.13% 123
2013
Q3
Sell
-7,600
Closed -$311K 665
2013
Q2
$311K Buy
+7,600
New +$344K ﹤0.01% 588

Other funds holding BCE

Grantham, Mayo, Van Otterloo & Co (GMO)'s BCE Position: Q4 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of BCE (BCE) in Q4 2017, closing a stake of 4,800 shares — an estimated $225K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCE in Q2 2013 and held it in 10 quarters. The position peaked at $86.8M in Q2 2016. 503 funds tracked by Wall St. Rank hold BCE as of Q4 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining BCE position as of Q4 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,800 BCE shares in Q4 2017, an estimated $225K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCE in Q2 2013 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s BCE position peaked at $86.8M in Q2 2016.
  • 503 funds tracked by Wall St. Rank held BCE as of Q4 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.